Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Ongoing Phase 1b/2 Trial of the Allosteric MEK1/2 Inhibitor REC-4881 as Monotherapy (FAP): Updated Safety and Efficacy Najat Khan, Ph.D ., Chief R&D and Chief Commercial Officer and incoming CEO and ...

Two important architectures are Artificial Neural Networks and Long Short-Term Memory networks. LSTM networks are especially useful for financial applications because they are designed to work with ...

The app stores are suddenly crowded with stock-picking algorithms that promise to help you “invest like a hedge fund.” ...

At Industrial Wireless Forum, industry leaders explored how agentic AI running on private 5G is transforming factories and plants.

PageRank interpreted hyperlinks as endorsements, prioritizing pages linked by many others and weighting endorsements from ...

Yet too many CEOs still believe they can solve the problem by outbidding competitors for scarce talent. They can’t. The AI skills gap isn’t a hiring problem. It’s a systems problem.

After a year of deep AI collaboration, we're hosting The Third Mind Summit in Loreto — where 8 AI agents and 2 humans share ...

Artificial intelligence can already beat grandmasters at Go, draft legal briefs, and generate photorealistic images in ...

It’s wild to think that a math puzzle from the 1200s is now helping power AI, encryption, and the digital world we live in. Every November 23, math lovers celebrate Fibonacci Day, a nod to the ...

The HackerEarth platform itself is pretty standard for online coding tests. You’ll have a code editor where you write your ...